Respiratory viruses are frequent causes of repeated common colds, bronchitis and
pneumonia, which often occur unpredictably as epidemics and pandemics. Despite those …

In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an
earlier‐than‐usual start (Weeks 35/2021–45/2022) and increased numbers of pediatric …

Human respiratory syncytial viruses (RSVs) are classified into two major groups (A and B)
based on antigenic differences in the G glycoprotein. To investigate circulating …

The emergence and reemergence of rapidly evolving RNA viruses—particularly those
responsible for respiratory diseases, such as influenza viruses and coronaviruses—pose a …

Respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections, is
classified in two major groups (A and B) with multiple genotypes within them. Continuous …

Worldwide G-glycoprotein phylogeny of human respiratory syncytial virus (hRSV) group A
sequences revealed diversification in major clades and genotypes over more than 50 years …

Two new prenylated dihydroquinolone derivatives, 22-O-(N-Me-l-valyl) aflaquinolone B (1)
and 22-O-(N-Me-l-valyl)-21-epi-aflaquinolone B (2), and two known analogues …

Respiratory illness (RI) accounts for a large proportion of mortalities in mountain gorillas
(Gorilla beringei beringei), and fatal outbreaks, including disease caused by human …

There is an ongoing global pandemic of human respiratory syncytial virus (RSV) infection
that results in substantial annual morbidity and mortality. In Australia, RSV is a major cause …

Respiratory syncytial virus (RSV) is an important pathogen of global significance. The BA9 is
one of the most predominant lineages of the BA genotype of group B RSV that has acquired …